Tizhi Wu

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update.

Zhiyu Li, Jinlei Bian, Tizhi Wu, 2020, Journal of medicinal chemistry.

Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity.

H. Ding, Tinghan Li, Zhiyu Li, 2019, European journal of medicinal chemistry.

Microwave-assisted unprotected Sonogashira reaction in water for the synthesis of polysubstituted aromatic acetylene compounds

Zhiyu Li, Jinlei Bian, Tizhi Wu, 2020 .

A patent review of selective CDK9 inhibitors in treating cancer

R. Chen, Zhiyu Li, Jinlei Bian, 2023, Expert opinion on therapeutic patents.

Design and optimization of selective and potent CDK9 inhibitors with flavonoid scaffold for the treatment of acute myeloid leukemia.

Ting Yu, Jing Zhang, Zhiyu Li, 2023, European journal of medicinal chemistry.

Discovery of novel flavonoid-based CDK9 degraders for prostate cancer treatment via a PROTAC strategy.

Xi Xu, Jinlei Bian, Zekun Du, 2023, European journal of medicinal chemistry.